View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Jan Erik Gjerland
  • Patrik Brattelius
ABGSC Credit Research ... (+2)
  • ABGSC Credit Research
  • Glenn Kringhaug

Solid but unexciting credit

Credit neutral Q1. A solid name among high yields. But bonds are largely de-risked and it shows in prices.

Nicolas David
  • Nicolas David

SAP : A good start to the year, but not enough (and too early) to rais...

>Solid Cloud & Software revenue, driven by on-premises resilience. Strong CCB - SAP released its Q1 2024 earnings yesterday after market. Sales were just in line, at € 8.04bn (css: € 8.02bn) but Cloud & Software revenue growth on cc came in at 11%, above expectations (css: 9% cc), thanks, again, to impressive resilience from the Support revenues (-1% cc vs css: -2.8% cc), while Cloud revenue growth was just in line with expectations (25% cc). The current Cloud backlo...

 PRESS RELEASE

EQS-News: Mayr-Melnhof Karton AG: MM reports first quarter 2024 result...

EQS-News: Mayr-Melnhof Karton AG / Key word(s): Quarter Results Mayr-Melnhof Karton AG: MM reports first quarter 2024 results 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Result below previous year as expected Significant volume growth at MM Board & Paper Continuity at a good level at MM Packaging Weak consumption continues to weigh on end markets Pressure on margins carries on Successful profit & cash protection programme will be continued Sales price development decisive for earnings situation in 2024 Group Key...

 PRESS RELEASE

EQS-News: Mayr-Melnhof Karton AG: MM veröffentlicht Ergebnisse zum 1. ...

EQS-News: Mayr-Melnhof Karton AG / Schlagwort(e): Quartalsergebnis Mayr-Melnhof Karton AG: MM veröffentlicht Ergebnisse zum 1. Quartal 2024 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Ergebnis erwartungsgemäß unter Vorjahr Deutlicher Mengenzuwachs bei MM Board & Paper Kontinuität auf gutem Niveau bei MM Packaging Konsumschwäche belastet weiterhin Endmärkte Margendruck hält an Erfolgreiches Profit & Cash Protection-Programm wird fortgesetzt Verkaufspreisentwicklung für Ergebnissituation 2024 entscheidend Ke...

ABGSC Capital Goods Research ... (+4)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Olof Cederholm
Chris Hoare
  • Chris Hoare

Rakuten (Reduce, TP: ¥400, -47%) Not on track to hit breakeven targets

Rakuten has seen stronger customer growth recently. In this note, we analyse whether Rakuten is on track to hit its target 8-10m customers and ¥2,500-3,000 ARPU by year end, and what this means for Rakuten’s target EBITDA breakeven by Dec 2024.

 PRESS RELEASE

EQS-News: OHB SE: Konzernabschluss 2023

EQS-News: OHB SE / Schlagwort(e): Jahresergebnis OHB SE: Konzernabschluss 2023 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. OHB SE: Konzernabschluss 2023 Gesamtleistung erreicht EUR 1.183 Mio. Dividendenvorschlag beträgt EUR 0,60 Freiwilliges öffentliches Übernahmeangebot schreitet planmäßig voran Der OHB-Konzern (ISIN: DE0005936124, Prime Standard) erreichte im Geschäftsjahr 2023 eine Gesamtleistung von EUR 1.182,8 Mio. (Vorjahr: EUR 1.001,3 Mio.), der Umsatz veränderte sich auf EUR 1.047,8 Mio. (Vorjahr: EUR...

 PRESS RELEASE

Cairn Homes Plc: Transaction in Own Shares

Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 23-Apr-2024 / 07:00 GMT/BST 23 April 2024   Cairn Homes plc (the “Company”) Transaction in own shares     The Company announces that on 22nd of April 2024 it purchased a total of 95,711 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Goodbody Stockbrokers UC (“Goodbody”), as detailed below. The repurchased shares will be cancelled.     Euronext Dublin London Stock Exchange Number o...

 PRESS RELEASE

EQS-News: OHB SE: Consolidated financial statements 2023

EQS-News: OHB SE / Key word(s): Annual Results OHB SE: Consolidated financial statements 2023 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. OHB SE: Consolidated financial statements 2023 Total revenues reach EUR 1,183 million Dividend recommendation amounts to EUR 0.60 Voluntary public takeover offer progressing according to plan In fiscal year 2023, the OHB Group (ISIN: DE0005936124, Prime Standard) generated total revenues of EUR 1,182.8 (previous year: EUR 1,001.3 million), while sales changed to EUR 1,047.8 milli...

 PRESS RELEASE

Full year trading update and notice of results

Molten Ventures Plc (GROW; GRW) Full year trading update and notice of results 23-Apr-2024 / 07:00 GMT/BST 23 April 2024   Molten Ventures plc ("Molten Ventures", "Molten", or the “Group”)   Full year trading update and notice of results    Stable and enhanced platform, in an improving market with greater expectation for realisations   Molten Ventures (LSE: GROW, Euronext Dublin: GRW), a leading venture capital firm investing in and developing high-growth digital technology businesses, today announces an update on its portfolio, NAV (unaudited) and highlights for the year ...

 PRESS RELEASE

EQS-News: DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTEN...

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Vancouver, BC, Canada, April 23rd, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce that its second-generation ARMTM anti-cancer vaccine using ...

 PRESS RELEASE

EQS-News: Screening completed: Berlin Cures achieves key milestone in ...

Issuer: Berlin Cures Holding AG / Key word(s): Miscellaneous Screening completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, Germany, 23 April 2024 – Berlin Cures, a pioneering clinical-stage biotechnology company, today announced the successful completion of patient screening for its pan-European Phase II trial of BC 007 (Rovunaptabin), a novel therapeutic candidate for the treatment of Long COVID. The study has now recr...

 PRESS RELEASE

EQS-News: ekrutierung abgeschlossen: Berlin Cures erreicht wichtigen M...

Emittent / Herausgeber: Berlin Cures Holding AG / Schlagwort(e): Sonstiges ekrutierung abgeschlossen: Berlin Cures erreicht wichtigen Meilenstein in der Phase-II-Studie mit BC 007 zur Behandlung von Long COVID 23.04.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, 23. April 2024 – Berlin Cures, ein Biotechnologieunternehmen in der klinischen Phase, hat heute den erfolgreichen Abschluss der Patientenrekrutierung für seine europaweite Phase-II-Studie mit BC 007 (Rovunaptabin) bekanntgegeben. BC 007 ist Berlin Cures‘ ...

United Airlines Holdings Inc: 1 director

A director at United Airlines Holdings Inc sold 30,000 shares at 50.843USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf

Dermapharm Holding SE : Smooth integration of Arkopharma and declining...

>2023 net earnings also burdened by accounting-related charges - While the final sales and EBITDA figures confirmed the preliminary results released on 14 March, the net result for 2023 published for the first time obviously led to disappointment in the market. The significant increase in financial expenses (c +400% to € 73m), together with the lower operating result (-25%) due to the absence of the vaccine business, led to a significantly lower net result of € 60.5m ...

Baptiste Lebacq
  • Baptiste Lebacq

Saipem : Q1 2024 slightly lower than expectations

>EBIT 2% below expectations - Q1 2024 sales came in 18% higher y-o-y at € 3.05bn (in line with the FactSet consensus at € 3.06bn). EBITDA came to € 268m, or a margin of 8.8% (below consensus of € 272m), driven by offshore businesses (€ 180m from asset-based services, € 80m for offshore drilling and € 8m for energy carriers). The energy carriers division continues to be undermined by challenging contracts. All told, this division’s EBITDA margin came to 0.7%, an...

ABGSC Construct. & Real Estate Research ... (+3)
  • ABGSC Construct. & Real Estate Research
  • Bengt Jonassen
  • Njål Kleiven
ABGSC Construct. & Real Estate Research ... (+4)
  • ABGSC Construct. & Real Estate Research
  • Fredrik Stensved
  • Markus Henriksson
  • Viktor Stenlöf
 PRESS RELEASE

The new UNIQLO x Marimekko collaboration collection brings joyful patt...

The new UNIQLO x Marimekko collaboration collection brings joyful patterns to a summer picnic Marimekko Corporation, Press release, 23 April 2024 at 9.00 a.m. EEST Finnish lifestyle design house Marimekko and global apparel retailer UNIQLO will launch a new limited-edition collaboration collection in May 2024. The collection is made of simple and comfortable UNIQLO pieces and Marimekko’s timeless archive patterns that showcase the brand’s art of printmaking. The UNIQLO x Marimekko Summer 2024 limited-edition collection includes items for all ages from women to children and babies...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch